Home/Pipeline/Axulin

Axulin

Not specified

CommercialActive

Key Facts

Indication
Not specified
Phase
Commercial
Status
Active
Company

About Housey Pharmaceutical Research Laboratories

Housey Pharma is a unique hybrid entity combining internal therapeutic development with a successful technology licensing business. Its core strategy involves leveraging proprietary, internally invented drug discovery platforms to advance its own pipeline while generating revenue through licensing agreements with major pharmaceutical companies like Novartis. The company's pipeline includes both prescription therapeutics and a marketed product, Axulin, and is supported by a leadership team and advisory board with deep industry and scientific expertise. Its dual model of platform licensing and product development positions it in both the technology and therapeutics sectors of biopharma.

View full company profile

Therapeutic Areas

Other Not specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved